World's Best Scientists 2026 revealed!
Terra L. Lasho

Terra L. Lasho

D-Index & Metrics

Medicine

D-Index
90
Citations
29174
World Ranking
12222
National Ranking
6262

Terra L. Lasho publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Terra L. Lasho sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 467 publications — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Terra L. Lasho D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Terra L. Lasho sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 90 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Terra L. Lasho is a researcher affiliated with the Mayo Clinic in the United States, with a substantial body of work spanning medicine, biochemistry, genetics, and molecular biology. Their research primarily focuses on hematology, genetics, and cancer-related fields, including acute myeloid leukemia and myeloproliferative neoplasms.

Lasho's publications reflect active contributions to several key topics, including:

  • Acute Myeloid Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Cancer Genomics and Diagnostics
  • Chronic Myeloid Leukemia Treatments
  • Protein Degradation and Inhibitors
  • Otitis Media and Relapsing Polychondritis

Their research has appeared frequently in high-impact journals, with notable publication venues comprising:

  • Blood
  • American Journal of Hematology
  • Leukemia
  • Leukemia Research
  • Haematologica

Recent papers authored or coauthored by Lasho include:

  • "Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera," 2020, British Journal of Haematology
  • "Spectrum of clonal hematopoiesis in VEXAS syndrome," 2023, Blood
  • "RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis," 2021, Nature Communications
  • "Single-cell genomics reveals the genetic and molecular bases for escape from mutational epistasis in myeloid neoplasms," 2020, Blood
  • "VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management," 2023, American Journal of Hematology

Lasho has collaborated regularly with several coauthors, indicating an active position in a network of hematology researchers. Frequent collaborators include:

  • Mrinal M. Patnaik
  • Christy Finke
  • Abhishek A. Mangaonkar
  • Naseema Gangat
  • Ayalew Tefferi

Their primary fields of study encompass medicine with 237 publications and biochemistry, genetics, and molecular biology with 77 publications. Within these fields, Lasho specializes in hematology, genetics, molecular biology, cancer research, and pathology and forensic medicine, with a publication distribution indicating a focus on hematology (111 publications) and genetics (77 publications).

Best Publications

  • MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

    Animesh D. Pardanani;Ross L. Levine;Terra Lasho;Yana Pikman

  • Long-term survival and blast transformation in molecularly-annotated essential thrombocythemia, polycythemia vera and myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Dirk R. Larson;Christy Finke

  • Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

    Ken Hong Lim;Ayalew Tefferi;Terra L. Lasho;Christy Finke

  • CALR vs JAK2 vs MPL -mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

    A Tefferi;T L Lasho;C M Finke;R A Knudson

  • The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.

    David P. Steensma;David P. Steensma;Gordon W. Dewald;Gordon W. Dewald;Terra L. Lasho;Terra L. Lasho;Heather L. Powell;Heather L. Powell

  • Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

    Ayalew Tefferi;Rakhee Vaidya;Rakhee Vaidya;Domenica Caramazza;Domenica Caramazza;Christy Finke;Christy Finke

  • TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis

    A. Tefferi;A. Pardanani;K. H. Lim;K. H. Lim;O. Abdel-Wahab

  • MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Mythri Mudireddy

  • JAK2V617F mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevance

    Alexandra P. Wolanskyj;Terra L. Lasho;Susan M. Schwager;Rebecca F. McClure

  • FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.

    Animesh Pardanani;Stephanie R. Brockman;Sarah F. Paternoster;Heather C. Flynn

  • TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations

    A Pardanani;J Hood;T Lasho;R L Levine

  • IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis

    A Tefferi;T L Lasho;O Abdel-Wahab;P Guglielmelli

  • Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera.

    A Pardanani;T L Lasho;C Finke;C A Hanson

  • The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Joannah Score

  • MIPSS70+ Version 2.0: Mutation and Karyotype-Enhanced International Prognostic Scoring System for Primary Myelofibrosis

    Ayalew Tefferi;Paola Guglielmelli;Terra L. Lasho;Naseema Gangat

  • Targeted deep sequencing in polycythemia vera and essential thrombocythemia

    Ayalew Tefferi;Terra L. Lasho;Paola Guglielmelli;Christy M. Finke

  • Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival

    A Tefferi;T L Lasho;J Huang;C Finke

  • CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients

    A Tefferi;P Guglielmelli;T L Lasho;G Rotunno

  • Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates

    Tefferi A;Levine Rl;Lim Kh;Lim Kh;Abdel-Wahab O

  • A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis.

    Ayalew Tefferi;Terra L. Lasho;Kebede H. Begna;Mrinal M. Patnaik

Frequent Co-Authors

Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Curtis A. Hanson
Curtis A. Hanson Mayo Clinic
Ruben A. Mesa
Ruben A. Mesa The University of Texas Health Science Center at San Antonio
Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Eric Solary
Eric Solary Institut Gustave Roussy
Mark R. Litzow
Mark R. Litzow Mayo Clinic
Paola Guglielmelli
Paola Guglielmelli University of Florence

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare is a smart move for students considering a career in medicine. Many accredited programs in nursing and advanced practice now offer online study options, making it more affordable and flexible to advance your career.

For those aiming to become nurse practitioners, enrolling in one of the cheapest fnp programs online can be a cost-effective way to gain expertise and boost job prospects. Students interested in leadership or specialized nursing roles should also look into the cheapest online msn programs, which provide the skills needed to move into management positions.

If you’re considering a future in academic research or higher-level practice, pursuing an online phd nursing can open doors to university faculty positions or specialized research roles. Meanwhile, practicing nurses who want to enhance their credentials and earning potential should consider the rn to bsn online cost options—these bridge programs offer a flexible, affordable way to advance quickly.

These online programs offer various entry points and career outcomes, giving aspiring healthcare professionals plenty of choices to fit their interests and schedules.

Best Scientists Citing Terra L. Lasho

Trending Scientists

Recently Published Articles